Average Co-Inventor Count = 4.14
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Celera Corporation (23 from 98 patents)
2. Berlex Laboratories, Inc. (6 from 100 patents)
3. Pharmacopeia Drug Discovery, Inc. (6 from 52 patents)
4. Other (3 from 832,680 patents)
5. Quest Diagnostics Investments, Inc. (3 from 479 patents)
6. Applera Corporation (1 from 496 patents)
7. Cetus Corporation (1 from 212 patents)
8. Pharmacopeia Inc. (1 from 101 patents)
9. Berlax Laboratories, Inc. (1 from 1 patent)
10. Celera Coporation (1 from 1 patent)
11. Lieden University Medical Center (lumc) (1 from 1 patent)
12. University of Texas System (5,444 patents)
13. Bristol-myers Squibb Compnay (3,681 patents)
14. Leiden University Medical Center (15 patents)
15. Leiden University Medical Center (lumc), Acting on Behalf of Academic Hospital Leiden (azl) (0 patent)
39 patents:
1. 12332236 - Methods for quantitation of insulin and C-peptide
2. 12077825 - Genetic polymorphisms associated with stroke, methods of detection and uses thereof
3. 12025610 - Methods for quantitation of insulin and C-peptide
4. 11814684 - Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof
5. 11708610 - Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
6. 11408034 - Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof
7. 11401555 - Genetic polymorphisms associated with stroke, methods of detection and uses thereof
8. 11124834 - Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
9. 11041209 - Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
10. 10988809 - Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof
11. 10982281 - Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
12. 10983108 - Methods for quantitation of insulin and C-peptide
13. 10584384 - Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof
14. 10550434 - Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
15. 10435749 - Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof